Amit Bardia, Mabel Wai, Manuel L Fontes. Curr Opin Anaesthesiol 2019
Times Cited: 7
Times Cited: 7
Times Cited
Times Co-cited
Similarity
Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review.
Venkatesan Thiruvenkatarajan, Emily Jane Meyer, Nagesh Nanjappa, Roelof M Van Wijk, David Jesudason. Br J Anaesth 2019
Venkatesan Thiruvenkatarajan, Emily Jane Meyer, Nagesh Nanjappa, Roelof M Van Wijk, David Jesudason. Br J Anaesth 2019
71
Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases.
Susan J Bersoff-Matcha, Christine Chamberlain, Christian Cao, Cindy Kortepeter, William H Chong. Ann Intern Med 2019
Susan J Bersoff-Matcha, Christine Chamberlain, Christian Cao, Cindy Kortepeter, William H Chong. Ann Intern Med 2019
42
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
42
42
Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery.
Anna Frisch, Prakash Chandra, Dawn Smiley, Limin Peng, Monica Rizzo, Chelsea Gatcliffe, Megan Hudson, Jose Mendoza, Rachel Johnson, Erica Lin,[...]. Diabetes Care 2010
Anna Frisch, Prakash Chandra, Dawn Smiley, Limin Peng, Monica Rizzo, Chelsea Gatcliffe, Megan Hudson, Jose Mendoza, Rachel Johnson, Erica Lin,[...]. Diabetes Care 2010
42
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
28
Hypoglycemia and risk of death in critically ill patients.
Simon Finfer, Bette Liu, Dean R Chittock, Robyn Norton, John A Myburgh, Colin McArthur, Imogen Mitchell, Denise Foster, Vinay Dhingra, William R Henderson,[...]. N Engl J Med 2012
Simon Finfer, Bette Liu, Dean R Chittock, Robyn Norton, John A Myburgh, Colin McArthur, Imogen Mitchell, Denise Foster, Vinay Dhingra, William R Henderson,[...]. N Engl J Med 2012
28
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother. Diabetes Metab Res Rev 2017
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother. Diabetes Metab Res Rev 2017
28
Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin Use: A Case Report.
Felicity Brown, Tamara McColl. J Emerg Med 2018
Felicity Brown, Tamara McColl. J Emerg Med 2018
28
SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Kelly R Burke, Christine A Schumacher, Spencer E Harpe. Pharmacotherapy 2017
Kelly R Burke, Christine A Schumacher, Spencer E Harpe. Pharmacotherapy 2017
28
The use of sodium-glucose co-transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?
Theocharis Koufakis, Omar G Mustafa, Ramzi A Ajjan, Xavier Garcia-Moll, Pantelis Zebekakis, George Dimitriadis, Kalliopi Kotsa. J Clin Pharm Ther 2020
Theocharis Koufakis, Omar G Mustafa, Ramzi A Ajjan, Xavier Garcia-Moll, Pantelis Zebekakis, George Dimitriadis, Kalliopi Kotsa. J Clin Pharm Ther 2020
28
SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications.
Emily J Meyer, Genevieve Gabb, David Jesudason. Diabetes Care 2018
Emily J Meyer, Genevieve Gabb, David Jesudason. Diabetes Care 2018
28
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
28
Debate on Insulin vs Non-insulin Use in the Hospital Setting-Is It Time to Revise the Guidelines for the Management of Inpatient Diabetes?
Francisco J Pasquel, Maya Fayfman, Guillermo E Umpierrez. Curr Diab Rep 2019
Francisco J Pasquel, Maya Fayfman, Guillermo E Umpierrez. Curr Diab Rep 2019
28
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).
Guillermo E Umpierrez, Dawn Smiley, Sol Jacobs, Limin Peng, Angel Temponi, Patrick Mulligan, Denise Umpierrez, Christopher Newton, Darin Olson, Monica Rizzo. Diabetes Care 2011
Guillermo E Umpierrez, Dawn Smiley, Sol Jacobs, Limin Peng, Angel Temponi, Patrick Mulligan, Denise Umpierrez, Christopher Newton, Darin Olson, Monica Rizzo. Diabetes Care 2011
28
Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.
Francisco J Pasquel, Roma Gianchandani, Daniel J Rubin, Kathleen M Dungan, Isabel Anzola, Patricia C Gomez, Limin Peng, Israel Hodish, Tim Bodnar, David Wesorick,[...]. Lancet Diabetes Endocrinol 2017
Francisco J Pasquel, Roma Gianchandani, Daniel J Rubin, Kathleen M Dungan, Isabel Anzola, Patricia C Gomez, Limin Peng, Israel Hodish, Tim Bodnar, David Wesorick,[...]. Lancet Diabetes Endocrinol 2017
28
Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment.
Guillermo E Umpierrez, Mary Korytkowski. Diabetes Care 2013
Guillermo E Umpierrez, Mary Korytkowski. Diabetes Care 2013
28
Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial.
Priyathama Vellanki, Neda Rasouli, David Baldwin, Sara Alexanian, Isabel Anzola, Maria Urrutia, Saumeth Cardona, Limin Peng, Francisco J Pasquel, Guillermo E Umpierrez. Diabetes Obes Metab 2019
Priyathama Vellanki, Neda Rasouli, David Baldwin, Sara Alexanian, Isabel Anzola, Maria Urrutia, Saumeth Cardona, Limin Peng, Francisco J Pasquel, Guillermo E Umpierrez. Diabetes Obes Metab 2019
28
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.
Peter Ueda, Henrik Svanström, Mads Melbye, Björn Eliasson, Ann-Marie Svensson, Stefan Franzén, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Björn Pasternak. BMJ 2018
Peter Ueda, Henrik Svanström, Mads Melbye, Björn Eliasson, Ann-Marie Svensson, Stefan Franzén, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Björn Pasternak. BMJ 2018
28
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Shelley R Salpeter, Elizabeth Greyber, Gary A Pasternak, Edwin E Salpeter. Cochrane Database Syst Rev 2010
Shelley R Salpeter, Elizabeth Greyber, Gary A Pasternak, Edwin E Salpeter. Cochrane Database Syst Rev 2010
28
Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes.
Meera Kotagal, Rebecca G Symons, Irl B Hirsch, Guillermo E Umpierrez, E Patchen Dellinger, Ellen T Farrokhi, David R Flum. Ann Surg 2015
Meera Kotagal, Rebecca G Symons, Irl B Hirsch, Guillermo E Umpierrez, E Patchen Dellinger, Ellen T Farrokhi, David R Flum. Ann Surg 2015
28
Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in the perioperative setting.
Sharon C Peacock, Julie A Lovshin. Can J Anaesth 2018
Sharon C Peacock, Julie A Lovshin. Can J Anaesth 2018
28
SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
28
Hyperglycemic crises in adult patients with diabetes.
Abbas E Kitabchi, Guillermo E Umpierrez, John M Miles, Joseph N Fisher. Diabetes Care 2009
Abbas E Kitabchi, Guillermo E Umpierrez, John M Miles, Joseph N Fisher. Diabetes Care 2009
28
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
28
Euglycemic diabetic ketoacidosis.
Leonid Barski, Tamar Eshkoli, Evgenia Brandstaetter, Alan Jotkowitz. Eur J Intern Med 2019
Leonid Barski, Tamar Eshkoli, Evgenia Brandstaetter, Alan Jotkowitz. Eur J Intern Med 2019
14
14
Class effects of SGLT2 inhibitors on cardiorenal outcomes.
Aaron Y Kluger, Kristen M Tecson, Andy Y Lee, Edgar V Lerma, Janani Rangaswami, Norman E Lepor, Michael E Cobble, Peter A McCullough. Cardiovasc Diabetol 2019
Aaron Y Kluger, Kristen M Tecson, Andy Y Lee, Edgar V Lerma, Janani Rangaswami, Norman E Lepor, Michael E Cobble, Peter A McCullough. Cardiovasc Diabetol 2019
14
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.
Ngozi Erondu, Mehul Desai, Kirk Ways, Gary Meininger. Diabetes Care 2015
Ngozi Erondu, Mehul Desai, Kirk Ways, Gary Meininger. Diabetes Care 2015
14
Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature.
Kushani Gajjar, Pooja Luthra. Cureus 2019
Kushani Gajjar, Pooja Luthra. Cureus 2019
100
Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols.
Tara T T Tran, Anthony Pease, Anna J Wood, Jeffrey D Zajac, Johan Mårtensson, Rinaldo Bellomo, Elif I I Ekinci. Front Endocrinol (Lausanne) 2017
Tara T T Tran, Anthony Pease, Anna J Wood, Jeffrey D Zajac, Johan Mårtensson, Rinaldo Bellomo, Elif I I Ekinci. Front Endocrinol (Lausanne) 2017
14
Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
Tory J Andrews, Robert D Cox, Christina Parker, James Kolb. J Emerg Med 2017
Tory J Andrews, Robert D Cox, Christina Parker, James Kolb. J Emerg Med 2017
14
Diabetic ketoacidosis with sodium-glucose cotransporter type 2 inhibitors: a case series.
Gina McLachlan, Claire Keith, Albert Frauman. Med J Aust 2019
Gina McLachlan, Claire Keith, Albert Frauman. Med J Aust 2019
50
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
14
Diabetic ketoacidosis associated to canagliflozin in type 2 diabetes.
Silvia González Sanchidrián, Juan Ramón Gómez-Martino Arroyo, Pedro Jesús Labrador Gómez. Med Clin (Barc) 2017
Silvia González Sanchidrián, Juan Ramón Gómez-Martino Arroyo, Pedro Jesús Labrador Gómez. Med Clin (Barc) 2017
50
Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.
Serge Jabbour, Jochen Seufert, Andre Scheen, Clifford J Bailey, Cathrina Karup, Anna M Langkilde. Diabetes Obes Metab 2018
Serge Jabbour, Jochen Seufert, Andre Scheen, Clifford J Bailey, Cathrina Karup, Anna M Langkilde. Diabetes Obes Metab 2018
14
Incidence of Ketoacidosis in the Danish Type 2 Diabetes Population Before and After Introduction of Sodium-Glucose Cotransporter 2 Inhibitors-A Nationwide, Retrospective Cohort Study, 1995-2014.
Majken Linnemann Jensen, Frederik Persson, Gregers S Andersen, Martin Ridderstråle, John J Nolan, Bendix Carstensen, Marit E Jørgensen. Diabetes Care 2017
Majken Linnemann Jensen, Frederik Persson, Gregers S Andersen, Martin Ridderstråle, John J Nolan, Bendix Carstensen, Marit E Jørgensen. Diabetes Care 2017
14
Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy.
Ryan B Dull, Mikayla L Spangler, Emily L Knezevich, Britney M Lau. J Pharm Pract 2019
Ryan B Dull, Mikayla L Spangler, Emily L Knezevich, Britney M Lau. J Pharm Pract 2019
33
Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors.
Michelle Isaacs, Katherine T Tonks, Jerry R Greenfield. Intern Med J 2017
Michelle Isaacs, Katherine T Tonks, Jerry R Greenfield. Intern Med J 2017
14
Euglycaemic ketoacidosis: a potential new hazard to plastic surgery day case and inpatient procedures.
Aseel Sleiwah, Michael McBride, Claire E Black. BMJ Case Rep 2017
Aseel Sleiwah, Michael McBride, Claire E Black. BMJ Case Rep 2017
33
SGLT2 Inhibitors May Predispose to Ketoacidosis.
Simeon I Taylor, Jenny E Blau, Kristina I Rother. J Clin Endocrinol Metab 2015
Simeon I Taylor, Jenny E Blau, Kristina I Rother. J Clin Endocrinol Metab 2015
14
Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter 2 Inhibitor Use in Two Patients Undergoing Pancreatectomy.
Devon J Pace, Katerina Dukleska, Samantha Phillips, Vanessa Gleason, Charles J Yeo. J Pancreat Cancer 2018
Devon J Pace, Katerina Dukleska, Samantha Phillips, Vanessa Gleason, Charles J Yeo. J Pancreat Cancer 2018
16
Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor.
Michael Fralick, Sebastian Schneeweiss, Elisabetta Patorno. N Engl J Med 2017
Michael Fralick, Sebastian Schneeweiss, Elisabetta Patorno. N Engl J Med 2017
14
DIABETIC KETOACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES RECENTLY COMMENCED ON SGLT-2 INHIBITORS: AN ONGOING CONCERN.
Mohamed Ahmed, Malachi J McKenna, Rachel K Crowley. Endocr Pract 2017
Mohamed Ahmed, Malachi J McKenna, Rachel K Crowley. Endocr Pract 2017
16
Sodium-glucose Cotransporter-2 Induced Diabetic Ketoacidosis with Minimal Hyperglycemia.
D Taylor Gammons, Francis L Counselman. Clin Pract Cases Emerg Med 2018
D Taylor Gammons, Francis L Counselman. Clin Pract Cases Emerg Med 2018
33
Diabetic Ketoacidosis Post Bariatric Surgery.
Ivania M Rizo, Caroline M Apovian. Front Endocrinol (Lausanne) 2019
Ivania M Rizo, Caroline M Apovian. Front Endocrinol (Lausanne) 2019
33
Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus.
Norm Rosenthal, Gary Meininger, Kirk Ways, David Polidori, Mehul Desai, Rong Qiu, Maria Alba, Frank Vercruysse, Dainius Balis, Wayne Shaw,[...]. Ann N Y Acad Sci 2015
Norm Rosenthal, Gary Meininger, Kirk Ways, David Polidori, Mehul Desai, Rong Qiu, Maria Alba, Frank Vercruysse, Dainius Balis, Wayne Shaw,[...]. Ann N Y Acad Sci 2015
14
Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives.
Hongyu Qiu, Aleksandra Novikov, Volker Vallon. Diabetes Metab Res Rev 2017
Hongyu Qiu, Aleksandra Novikov, Volker Vallon. Diabetes Metab Res Rev 2017
14
Physician experiences with sodium-glucose cotransporter (SGLT2) inhibitors, a new class of medications in type 2 diabetes, and adverse effects.
Laura Patakfalvi, Anne-Sophie Brazeau, Kaberi Dasgupta. Prim Health Care Res Dev 2018
Laura Patakfalvi, Anne-Sophie Brazeau, Kaberi Dasgupta. Prim Health Care Res Dev 2018
20
Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy.
Eleni Papadokostaki, Evangelos Liberopoulos. Case Rep Endocrinol 2019
Eleni Papadokostaki, Evangelos Liberopoulos. Case Rep Endocrinol 2019
50
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.